This is an extraordinary and ambitious collaboration and locations project between the G. Giglio Institute Foundation in Cefalù and the Agostino Gemelli IRCCS University Hospital Foundation in Rome, a reference for Italian and international healthcare.
The initiative stems from the desire to combine excellence in clinical, surgical and scientific fields.
The Fondazione Istituto Giglio di Cefalù was founded in 2003 to create a center of excellence in Sicily with a prevalence of oncology and with the task of carrying out health care activities, in various forms of prevention, treatment and rehabilitation at international standards of excellence.
It manages the hospital of the same name, based in Cefalù in the province of Palermo, which has become a reference center for the healthcare of the region.
Through the implementation of biomedical, experimental and clinical research programs, training and knowledge transfer programs, and the enhancement of internal resources, Gemelli Giglio Medical Partnership is a candidate to become a flagship of innovative healthcare.
For more information, please visit the website
Since July 2018, Gemelli Molise has been fully integrated into the scope of the clinical-care offer of the Agostino Gemelli IRCCS University Hospital Foundation.
With its 130 beds and the recognized quality of the specializations in the fields of oncology and cardiovascular diseases, Gemelli Molise locations Campobasso is an important health reference place for the whole area of south-eastern Italy. It provides clinical-assistance activities of excellence as well as hosting degree courses in Nursing, Medical radiology techniques for images and radiotherapy and Physiotherapy at the Catholic University of the Sacred Heart of Rome and promoting refresher courses, conferences and training events for health professionals.
Since July 2018, the Fondazione Policlinico Universitario Agostino Gemelli IRCCS has been fully integrated into the clinical-care perimeter of Gemelli Molise and this has made it possible to further improve the quality of the services offered to the Molise locations and neighbouring regions, as well as to be able to achieve important synergies in sharing common services, combining two fundamental objectives of greater effectiveness of care and greater efficiency in management.
Since 2008, it has obtained “Women’s Hospital” recognition from the National Observatory on Women’s Health (O.N.Da). In 2016 the quality of the services rendered by Gemelli Molise was also certified by the National Outcome Plan (PNE), the tool with which the National Agency for Regional Health Services (AGE.N) develops the assessment in the Italian Health Service of the outcomes of health interventions.
The hospital is also equipped with a cutting-edge and constantly improving technology park. Since September 2002, 'Molise ART' Radiotherapy has been the only Radiation Therapy Center in Molise, collaborating closely with all the oncological realities of the region and surrounding areas. To date, more than 13,500 patients have been clinically evaluated and the most modern and sophisticated techniques for setting up and executing radiotherapy treatments have been used. Molise ART has a dedicated 4D TC simulator, and treatment planning systems that use advanced algorithms of artificial intelligence, Montecarlo calculation and radiobiological optimization. The two linear accelerators are of the latest generation with collimation systems of the radiant beams with millimetre precision, control of the patient’s breath, verification of his positioning also of an optical type with body surface reconstruction, robotic treatment table and 3D/4D image verification systems.
With about 1,000 scientific publications, Gemelli Molise has since its origins, engaged in scientific research, with particular regard to the field of oncology and cardiovascular diseases, in which clinical practice is valued in order to ensure "patient-oriented" management. It also actively collaborates with the Gemelli Molise research laboratories in the field of genomics and radiomics.
For more information please visit the website
Mater Olbia Hospital is the result of the partnership between the Qatar Foundation Endowment and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Rome who have decided to combine the skills and experiences to create a cutting-edge and excellent hospital. In the amazing Sardinian locations.
The facility started its first outpatient activities in December 2018, and hospitalization activities began on 1st July 2019. Already in the first months of activity in 2019, the number of accredited beds was 202, of which 72 for rehabilitation activities, which became fully active in 2020.
The facility has 250 beds, out of which 50 are located on the top floor with a breathtaking sea view and dedicated to international patients. Mater Olbia offers a wide range of highly specialized medical services, including neurology, orthopaedics, physiotherapy, interventional radiology, obesity/bariatric surgery, endoscopy, neurosurgery, and gynaecology, breast care and a state-of-the-art radiotherapy centre.
The Mater Olbia ART Radiotherapy Center, was officially opened in 2020 with the latest technology in the field of radiation oncology: ETHOS Therapy and MRIdian MRI-guided Linac. The Zap-X Gyroscopic Radiosurgery for the brain is currently being installed and will be open for use over the upcoming years.
For more details about this modern and state-of-the-art hospital in a picturesque location, please visit its website at the following link
Link
XBioGem is a company created from the partnership between the Policlinico Universitario A. Gemelli IRCCS and BioRep, a Gruppo Sapio company specialising in cryopreservation services. It provides laboratory services and storage of biological material services to public and private research institutes, guaranteeing the highest levels of quality and safety.
The high-quality specialization, the state-of-the-art technologies that the company offers and the standardization of the most advanced techniques for material sampling make XBioGem the benchmark provider of biological samples and of high-quality laboratory services, able to create and provide useful data for successful scientific research.
In fact, one of the company’s objectives is to create and manage a biobank aimed at collecting, storing and distributing human biological samples that can support research activities in the academic field, in addition to developing collaborations with the pharmaceutical industry, biotech industry and public and private medical centres and laboratories.
Specifically, XBioGem is specialized in preparing cell lines, extracting nucleic acids, and long-term storing of various samples of biological material in liquid nitrogen (-196°C), in nitrogen vapours (-156°C) and in mechanical freezers (-80°C).
Using a management software platform of the reliable sample guarantees traceability during all the procedural and storage phases allowing it to be identified, registered and filed through a unique bar code. In addition, it offers high-quality molecular biology services (among which the purification of nucleic acids, sequencing, and genotyping) and cellular biology services (isolates, captures, preserves and distributes cellular lines and DNA of these by-products.
In June 2019, Gemelli and XBioGem inaugurated the first National Biobank dedicated to research on ALS (Amyotrophic Lateral Sclerosis).
For more information, please visit the website
The Gemelli Health System (GHS) is a company created within the Fondazione Policlinico Universitario Agostino Gemelli and deals with personalized therapies obtained thanks to mixtures of micronutrients.
GHS is committed to implementing treatments with nutrient mixtures for rare diseases and specific patients, with approaches increasingly personalized that enhance Gemelli’s commitment, closing the gaps in the offer of micronutrients and macronutrients.
The idea of a company focused on "Alimenti a Fini Medici Speciali" (AFMS) (Special Medical Foods) came from the implementation, put into effect by the Policlinico Gemelli experts, of a European guideline named ERAS, created with the intent to improve the patient’s operative and post-operative care.
All doctors at the Gemelli take part in this project and have put into practice the ERAS guideline through the use of nutrient mixtures (NutriCatt) in order to make a line of Special Medical Foods available, that is capable of responding to the specific wellness request, that doctors receive from patients and their families on a daily basis.
Each GHS product is created by choosing active principles and nutrients that have been carefully selected, containing absolutely no pollutants or impurities, in order to guarantee a final product that offers the best quality to each patient, according to his or her individual needs.
GHS will make a toll-free number available specifically to provide information and will make its products available to patients all over Italy through a logistic network and a certified productive supply chain.
For more information please visit the website
